Trust Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Trust Investment Advisors's GILD Position: Q1 2023 in Review
Trust Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 2,802 shares — an estimated $241K sold.
Trust Investment Advisors first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $889K in Q4 2021. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.
- Trust Investment Advisors reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
- Trust Investment Advisors sold 2,802 Gilead Sciences shares in Q1 2023, an estimated $241K.
- Trust Investment Advisors first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
- Trust Investment Advisors's Gilead Sciences position peaked at $889K in Q4 2021.
- 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.
Based on Trust Investment Advisors's 13F filing for Q1 2023, filed 12 May 2023.